For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Solifenacin - Overactive bladder (adults)
PAD Profile : Solifenacin - Overactive bladder (adults)
Traffic Light Status
Status 1 of 3.
- Tablets
Status 2 of 3.
- Oral suspension
Status 3 of 3.
Guidelines
The following guidelines are available for this indication.
Other Drugs
- Darifenacin hydrobromide
- Flavoxate hydrochloride
- Oxybutynin
- Propiverine hydrochloride
- Mirabegron
- Fesoterodine fumarate
- Trospium chloride
- Tolterodine
- Imipramine hydrochloride
Other Indications
No indications returned.
Additional Documents
Committee Recommendations
The APC supports patients in trialling a treatment break of their overactive bladder medicines.
A "Leaflet for trial of stopping anticholinergics" can be found in the documents section below.
Solifenacin is the 1st line treatment option.
Patients with swallowing difficulties
Solifenacin 1mg/ml oral SUSPENSION sugar free is the preferred option in patients with swallowing difficulties.
Solifenacin 5mg/5ml oral solution is non-formulary due to it being significantly more expensive than the suspension in primary care.
See Selection Tool for locally agreed OAB treatment options